Bacteriophage therapy is a promising new treatment that may help overcome the threat posed by antibiotic-resistant pathogenic bacteria, which are increasingly identified in hospitalised patients. The development of biocompatible and sustainable vehicles for incorporation of viable bacterial viruses into a wound dressing is a promising alternative. This paper evaluates the anti-microbial efficacy of Bacteriophage K against Staphylococcus aureus over time, when stabilised and delivered via an oil-in-water nano-emulsion. Nano-emulsions were formulated via thermal phase inversion emulsification, and then bacterial growth was challenged with either native emulsion, or emulsion combined with Bacteriophage K.
INTRODUCTION
The rise in antibiotic resistant bacteria such as methicillin resistant Staphylococcus aureus (MRSA) is widely reported 1 , but the rate of development of new antibiotics to treat these emerging 'superbugs' is low 2 . Only Linezolid has been approved for the treatment of acute skin infections since 2000 3 , although Tedizolid is currently being developed 4 . Skin is the primary defence mechanism against infection 5 ; hence injuries or burns constitute significant pathways for bacterial infection. Burns are especially susceptible to bacterial colonization with an estimated 10% of all burn injuries becoming infected 6 . Infection consequences include increased patient morbidity and mortality, and increased cost of treatment 7, 8 due to prolonged hospitalisation. Staphylococcus aureus (MRSA) is the most frequently detected antibiotic-resistant pathogen in hospitals worldwide 9, 10 . The lack of effective new antibiotics has led to interest in alternative therapies 11 , including antimicrobial peptides 12 , microbial therapy, and the use of viruses that kill bacteria 13, 14 . Such bacterial viruses, called bacteriophages or phages, attach to bacterial cell surfaces, use them as a host for their own replication, and eventually produce bacterial lysis. Bacteriophages therefore have potential for control of microbial infections 15 .
Therapeutic use of bacteriophages dates from the 1930s and they are now being reconsidered as alternatives to antibiotics. The advantages of bacteriophage therapy include their capacity to infect bacterial cells, their abundance and ecological 'friendliness'. They can be used as a 'phage-cocktail', they multiply exponentially, and they do not affect human microflora and hence do not generate unwanted side-effects 16 . However, their broad diversity presents a challenge to our detailed understanding of their potential 17 . Bacteriophages have been used against skin and wound infections, with success rates up to 90% against Staphylococcus aureus, Klebsiella pneumoniae and Pseudomonas aeruginosa 14 . Phage cocktails have been shown to increase survival significantly in mice with burn wound injuries 18 , and used in ear infections of dogs 19 . Once a safe phage or 'phage-cocktail' has been identified, the aim is to deliver it to the point of infection without losing efficacy, either during delivery or storage.
Surface burns are normally treated via cleaning to remove dead tissue, and covering the burn in a dressing to promote re-epithelisation and reduce or prevent infection. Various antimicrobial wound dressings are available, including Acticote TM , a silver-containing dressing.
However, recent analysis of anti-microbial wound dressings has queried their effectiveness compared to passive alternatives 20 .
Nano-emulsions provide enhanced biocompatibility compared to emulsions as they require less surfactant, which may affect the skin at high concentration 21 . Additionally the small droplet size allows greater penetration and distribution through the skin compared to emulsions 22, 23 . A benefit of nano-emulsions as carriers of bacteriophage is prevention of aggregation 24 which can result in precipitation and loss of biological activity. Nanoemulsions can also provide stability in long-term phage storage without a significant decrease in infectivity 25 . Oil-in-water emulsions enhance transdermal penetration, and depending on the composition and the use of thickeners, numerous formulations can be achieved. However screening the wide variety of potential emulsion formulations is a challenge when looking for biocompatibility so careful design of experiments is essential. The efficacy of encapsulation for delivery and storage of bacteriophage has been demonstrated 26, 27 . Nevertheless, phage infectivity and survival may be influenced by formulation composition [28] [29] [30] [31] [32] [33] [34] [35] , which can damage phage structural components. Phage may be exposed to abnormal environmental conditions such as the emulsion components themselves. Furthermore, the compounds present in the nano-emulsion may influence bacterial growth itself, and thus mask the specific effect of the phage.
This work evaluates the in vitro anti-microbial efficacy of Bacteriophage K when stabilised in an oil-in-water nano-emulsion, compared to simple delivery as an aqueous dispersion.
Bacteriophage K is lytic for a wide range of S. aureus strains as well as other staphylococcithree strains are selected here. The emulsion / phage formulation will form the basis for development of a wound dressing or topical cream, containing stabilised phage.
MATERIALS AND METHODS

Chemicals
Brij® O10 (Polyoxyethylene (10) oleyl ether), soybean oil, Tryptic soy broth (TSB), tryptic soy agar (TSA), NaCl, MgSO4·7H2O, Tris-Cl, and gelatine were purchased from SigmaAldrich (Dorset, UK). Reverse Osmosis water was produced in the laboratory.
Bacterial and bacteriophage strains
Staphylococcus aureus strains H560, H325, and Btn766 (Bacteriophage K sensitive strains),
and Bacteriophage K, were obtained from AmpliPhi Biosciences (Bedfordshire, UK).
Emulsification method
Thermal phase inversion emulsification was used 36, 37 to produce formulations containing 5%
(w/w) soybean oil as the organic phase, 15% (w/w) Brij O10® as surfactant, and 80% (w/w) SM buffer (100 mM NaCl, 8 mM MgSO4·7H2O, 50 mM Tris-Cl, 0.002% (w/v) gelatin, pH 7.5) as the aqueous phase. The relatively high concentration of emulsifier allowed the more pronounced effects on bacterial growth and bacteriophage infectivity to be detected during a shorter storage time. The presence of SM buffer as the aqueous phase resulted in smaller emulsion droplets (via the salting out effect) and stabilised pH to an appropriate value for bacteriophage storage. The emulsion components were initially sterilised by filtration, and formulation took place under aseptic conditions. Brij O10® was added to the corresponding amount of SM buffer under mixing, and the required amount of soybean oil was added.
Stirring continued for at least one hour until a homogenous mixture was achieved (complete dissolution of emulsifier). 
Incorporation of bacteriophage into emulsions
The introduction of Bacteriophage K into the emulsion required dilution of the phage lysate to a concentration that lead to a noticeable decrease in bacterial growth, as indicated by a reduction in optical absorbance. Dilutions were made using emulsion as both diluent and storage media. The final concentration of bacteriophage used for infectivity tests corresponded to a multiplicity of infection (MOI) of about 0.1. Bacteriophage-emulsion preparations were kept either at room temperature (18-20°C) or cold temperature (4°C) over ten days and their ability to infect bacteria was tested regularly.
Plaque assays and colony counting
Standard colony counting was used to quantify bacterial concentration (colony forming units, CFU ml -1 ) and standard plaque assays were used to measure bacteriophage concentration (plaque forming units, PFU ml -1 ) using overnight cultures of the tested strain with an initial optical density (O.D) of 1 -1.5 absorbance units (a.u) at 600 nm, or about 10 8 CFU ml -1 .
Plaque assays could only be used for the quantification of bacteriophage infectivity in buffer, as the effect of the emulsion on the growth of the bacterial lawn was not measurable via this technique. Therefore, a fair comparison between free phage suspension and phage-emulsion formulations was not possible via standard PFU counting.
Measurement of turbidity of bacterial samples
Visual PFU counting may lead to errors and lack of reproducibility, hence optical density measurement was used as an alternative, as the turbidity of bacteria cultures in TSB should be reduced by the lytic action of bacteriophage. Variation of optical density with time was measured in triplicate via 96 multi-well plates, using a micro-plate reader (SPECTROstar Omega, BMG LABTECH). Measurements took place overnight for approximately 15 hours at 37°C and 600 nm, as a simulation of bacterial growth and phage infection in the incubator.
Measurement of infectivity of bacteriophage preparations
Bacteriophage infectivity was followed by the decrease in optical density of bacterial suspensions. Bacterial growth was challenged with either aqueous suspensions of bacteriophage in SM buffer, or bacteriophage-emulsion preparation, all in triplicate. The initial concentration of bacteriophage was the same in each case and equivalent to a MOI of 0.1. The initial bacterial concentration was equivalent to 1 a.u., corresponding to about 10 8 CFU ml -1 . As samples comprised 100 μl of the appropriately diluted overnight bacterial culture, and 100 μl of the corresponding bacteriophage formulation, the MOI was preserved.
The optical density of samples was measured at 600 nm for approximately 15 hours at 37°C.
The bacteriophage-emulsion formulation was stored for a 10 day period, and infectivity was measured over time by taking samples and running growth curves and measuring the final bacterial concentration after the 15 hour treatment for each sample.
Characterisation of emulsions and stability
Droplet size can determine the stability of emulsions as it influences the possibility of coalescence or creaming. This was measured using a ZETASIZER Nano Series (Malvern Instruments), based on the principle of dynamic light scattering (DLS) and Brownian motion of particles. Samples needed to be suitably diluted in water or buffer before being subjected to measurement. The stability of emulsions was also tracked via measurement of optical density over time 38 using the micro-plate reader.
Surface response experimental design to evaluate the influence of emulsion formulation on bacterial growth and bacteriophage infectivity
A mixture containing emulsion droplets, bacteriophage, and bacteria could result in complex interactions between any pair of components, or all three. To understand the relative influence of these three components, experiments were designed using Response Surface Methodology (RSM). The main objective was to evaluate the effect of emulsion droplet concentration on bacterial growth under different growth conditions, and to detect variations in bacteriophage infectivity when emulsion was present. RSM was selected as the relationship between these variables was initially unknown. Experiments were designed using Minitab16® (Minitab Statistical Software), and experiments were randomised to meet the statistical assumptions and reduce the effects of other factors. Initial concentration of bacteria and the bacteria : emulsion droplet ratio were the factors used to study bacterial growth in emulsion for each of the bacterial strains and the different levels selected for each factor are presented in Table 1 . Growth rate and carrying capacity were the response variables characterised in relation to bacterial growth. Values for these parameters were estimated from the Verhulst (logistic) model of population growth (Equation 1). [1] where N(t) is the concentration of bacteria (CFU ml -1 ), t is time (h), a is the growth rate of the bacterial population (h -1 ), and C is the carrying capacity or maximum population size (CFU ml -1 ). The logistic growth curve was preferred as it gives a reasonable fit despite its simplicity 39 . Bacterial growth was measured by turbidity assays (600 nm) at 37°C with orbital agitation for 20 hours, under the conditions specified by the experimental design, using six replicates. Optical density growth curves were used to estimate the parameters in the integrated form of the Vershulst model (Equation 2) using Origin 8 software (OriginLab, Northampton, MA) 40 .
[2]
Here OD(t) is optical density of bacteria at time t (a.u.) -equivalent to N(t) in Equation 1, t is time (h), a is the growth rate of the bacterial population (h -1 ), B is an integration constant, and C is the carrying capacity or maximum population size (a.u.) as before. A non-linear least squares error minimisation algorithm was used to estimate the parameter values.
Three parameters were considered for the factorial study of bacteriophage infectivity: the initial concentration of bacteria, the bacteria : emulsion droplet ratio, and the initial concentration of bacteriophage for each of the bacterial strains. The factor levels are listed in Table 1 . The response variable was the final concentration of bacteria after contact with the bacteriophage-emulsion preparation (20 hours).
RESULTS AND DISCUSSION
Characterisation of emulsions
Nano-emulsions prepared using the PIT method were transparent, with a droplet size of about 20 nm, as previously reported for this formulation (5% (w/w) Soybean oil, 15% (w/w) Brij O10® surfactant, 80% (w/w) SM buffer) 41 . Nano-emulsions remained clear and transparent to the naked eye during the 10 day testing period, and optical density was also constant. No clouding, phase separation or coalescence was observed when stored at room or cold temperature. Nano-emulsion stability is not only caused by the small droplet size, but also by the narrow droplet size distribution 36 .
Influence of emulsion on bacterial growth
The measurements of bacterial OD were all performed in triplicate, with average values being plotted in Figures 1 to 3 . One in five of the error bars (representing standard deviation of the replicates) are presented for clarity. Nano-emulsion and TSB are virtually transparent at 600 nm; however, their baseline OD was subtracted from the raw data and appropriate propagation of errors was performed. when emulsion was present, if compared with normal growth in TSB. Figure 3 shows that S.
aureus Btn766 growth differed from H560 and H325 mainly in the 1:1 diluted emulsion, with lag period of almost 5 hours, a concentration peak at about 9 hours, and a slight decline before the stationary phase. When Btn766 was grown in 1:1 or 1:10 emulsion dilutions the final bacterial concentration was about the same, at almost 33% less than in TSB.
To summarise, strains H560, H325, and Btn766 experienced the slowest growth when they were grown in 1:1 diluted emulsion. The maximum concentration of bacteria achieved was also affected, mainly being reduced for strains H325 and Btn766 growing in 1:10 and 1:1 nano-emulsion dilutions (Figures 2 and 3) . The slight decrease in bacterial concentration at the end of the measurement period was attributed to the gravitational deposition of bacteria on the wells. The growth was generally slower in the presence of emulsion, but there was no apparent overall growth inhibition or antimicrobial effect, which is supported by the literature [42] [43] [44] . The distinctive growth patterns for the three bacterial strains suggest that variations in growth might be related to the specific metabolism of each strain. Bacteria tend to grow in the aqueous phase of food-related emulsion formulations, and the presence and concentration of emulsion droplets constitutes an important factor that can influence bacterial growth 45, 46 . The observed decelerating effect of emulsions on bacterial growth is supported by published work, where E. coli is shown to grow slower when higher concentrations of emulsion were present in the growth medium 47 . These authors summarise possible explanations for this phenomenon as being impeded diffusion of nutrients through the organic phase, spatial limitations between bacteria and emulsion droplets, and facilitated accumulation of waste products, leading to growth inhibition. Interactions between emulsion droplets and bacteria have been shown to take place mainly due to electrostatic interactions 48 .
This paper shows that emulsions formulated with non-ionic surfactants did not show changes in droplet size, and concludes that interactions bacteria and emulsion droplets did not affect emulsion stability. In our work, a non-ionic surfactant was used and the emulsion droplet size was in the range of nanometres. This explains the lack of variation in emulsion transparency when bacteria were present. However, it is clear that appropriate controls are required when bacteriophage and bacteriophage-emulsion formulations are tested against S. aureus, if they are to be effectively compared. When bacteriophage infectivity was tested, bacterial growth in TSB was selected as the control, whilst bacterial growth in emulsion was chosen as the control for bacteriophage-emulsion formulation testing. In this way the killing effects of phage, measured via reduction in bacterial OD, may be effectively compared. The influence of nano-emulsions on bacterial growth also prevented the use of standard plaque forming unit assays for the quantification of bacteriophage infectivity. This restricted the CFU and PFU counting methods to the determination of initial concentrations of bacteria and bacteriophage.
Efficacy of bacteriophage preparation
Measurements were performed in triplicate, and one in five of the error bars, representing the an emulsion 49 . Bacteriophages may be protected against inactivation due to electrostatic interactions between bacteriophage surface proteins and nano-emulsion droplets 50 . This shielding mechanism, which could preserve lytic activity, and combined with more favourable contact between bacteriophage and bacteria in the presence of emulsion, could result in an enhanced killing effect. The literature suggests that certain surfactants (e.g. emulsan) do not interfere with phage binding to bacterial surfaces; moreover the binding occurs at the emulsion interface 51 .
Surface response experimental design to evaluate the influence of emulsions on bacterial growth and bacteriophage infectivity
Enhancement of infectivity of Bacteriophage K against S. aureus by nano-emulsion has been demonstrated (Figures 4 -6 ), but the mechanisms of enhancement are not specifically understood. Factorial experimental design followed by RSM analysis was used to identify the most influential variables in the system on bacterial growth and bacteriophage infectivity. (Table 1) .
Bacterial growth may be influenced by attachment of emulsion droplets to the outer cell membrane, causing a switch in metabolism, for instance inducing anaerobic behaviour due to the lack of available oxygen, or depriving bacteria of nutrients present in the medium.
Emulsion droplets may also contribute to more effective bacteria-bacteriophage interaction, creating a framework that reduces adsorption distances. These effects may combine to influence both bacterial growth and phage-bacterial binding mechanisms. The significance of the experimental factors was determined by the Fisher test, which compares the p-values from the statistical software with a fixed value, α, at the desired confidence level. In this case 95% confidence was selected (α = 0.05), and the influence of any factor was considered significant if its corresponding p-value was < 0.05.
The most influential factors on bacterial growth rate were the initial concentration of bacteria (p-value=0.000) and the dilution factor of emulsion (p-value=0.000). The physical meaning of these is understandable, and the relationships are confirmed in Figure 7 .
For bacterial carrying capacity, the most influential factors were emulsion concentration (p- When final bacterial concentration was tested against varying bacteriophage-emulsion preparations, the most important factor was initial bacterial concentration (p-value=0000).
The interaction of these factors is shown in and 7E for strains H325 and Btn766. For the more concentrated emulsion (1:1 dilution) the large number of droplets could inhibit nutrient uptake by the bacteria. However, the optimum growth rate varies from strain to strain depending on the initial bacterial concentration. For all initial concentrations of bacteria, growth in more dilute emulsions yielded higher growth rates. The dilution factor of emulsions had a slight effect on bacterial carrying capacity, supporting a greater capacity for the most diluted emulsion. In Figure 7B , 7D and 7F, H560 achieved the maximum number of bacteria with the higher dilution factor
(1:100) leading to a higher carrying capacity. A less obvious effect is seen with Btn766.
To summarise, emulsion formulations with least effect on bacterial growth were those that were diluted, supporting the hypothesis that droplets might inhibit the uptake of oxygen or nutrients by bacterial cells. If the killing effect of bacteriophage in dilute emulsions is high compared to the enhanced lytic activity seen with more concentrated emulsion (1:1 dilution), then dilute formulations would be selected as they affect bacterial growth less. Figures 8C and 8I show that for an initial bacteriophage concentration of 1×10 -4 PFU ml -1 , diluted emulsions give greater killing effect for medium to high initial concentrations of H560, and medium initial concentrations of Btn766. The killing effect of H325 at medium to high initial concentrations of bacteria is not affected by the emulsion dilution factor ( Figure   8F ). The highest and medium initial concentrations of bacteria gave the lowest final bacteria concentration, so more concentrated emulsions generally give the highest killing effect.
Shelf-life of bacteriophage -emulsion preparations
A relative killing effect was defined, Equation 3 , to compare the lytic activity of bacteriophage in buffer suspension with bacteriophage-emulsion formulations.
[3]
Optical density (OD) is equivalent to bacterial concentration. Hence, the relative killing Six replicates were performed for each of the factor combinations. 
